The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Mechanism of Action of Colchicine in the Treatment of Gout
Open accessAbstract
PURPOSE: The aims of this article were to systematically review the literature about the mechanism of action of colchicine in the multimodal pathology of acute inflammation associated with gout and to consider the clinical utility of colchicine in other chronic inflammatory diseases. METHODS: The English-language literature on PubMed was searched for articles published between 1990 and October 2013, with a cross-reference to citations across all years. Relevant articles pertaining to the mechanism of action of colchicine and the clinical applications of colchicine in gout and other inflammatory conditions were identified and reviewed. FINDINGS: The molecular pathology of acute inflammation associated with gouty arthritis involves several concurrent pathways triggered by a variety of interactions between monosodium urate crystals and the surface of cells. Colchicine modulates multiple pro- and antiinflammatory pathways associated with gouty arthritis. Colchicine prevents microtubule assembly and thereby disrupts inflammasome activation, microtubule-based inflammatory cell chemotaxis, generation of leukotrienes and cytokines, and phagocytosis. Many of these cellular processes can be found in other diseases involving chronic inflammation. The multimodal mechanism of action of colchicine suggests potential efficacy of colchicine in other comorbid conditions associated with gout, such as osteoarthritis and cardiovascular disease. IMPLICATIONS: Colchicine has multiple mechanisms of action that affect inflammatory processes and result in its utility for treating and preventing acute gout flare. Other chronic inflammatory diseases that invoke these molecular pathways may represent new therapeutic applications for colchicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,572
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
A Light and Electron Microscopic Study
Schochet, S. S., McCermick, W. F., & F, G. F. (1976) · Cited by 1,642
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A., & Thompson, P. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.027 · Cited by 1,054
The role of cytokines in osteoarthritis pathophysiology
Fernandes, J. C., Martel‐Pelletier, J., & Pelletier, J. (2002) · Biorheology: The Official Journal of the International Society of Biorheology · doi:10.1177/0006355x2002039001002025 · Cited by 1,015
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
Misawa, T., Takahama, M., Kozaki, T., Lee, H., Zou, J., Saitoh, T., & Akira, S. (2013) · Nature Immunology · doi:10.1038/ni.2550 · Cited by 855
Tetlow, L. C., Adlam, D. J., & Woolley, D. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<585::aid-anr107>3.0.co;2-c · Cited by 736
Khanna, D., Khanna, P. P., Fitzgerald, J. D., Singh, M. K., Bae, S., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21773 · Cited by 728
Self-citationNALPs: a novel protein family involved in inflammation
Tschopp, J., Martinon, F., & Burns, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1019 · Cited by 723
Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease
Choi, H. K., & Curhan, G. (2007) · Circulation · doi:10.1161/circulationaha.107.703389 · Cited by 666
Colchicine poisoning: the dark side of an ancient drug
Finkelstein, Y., Aks, S. E., Hutson, J. R., Juurlink, D. N., Nguyen, P., Dubnov-Raz, G., Pollak, U., Koren, G., & Bentur, Y. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.495348 · Cited by 589
American College of Rheumatology guidelines for management of gout
Khanna, D. (2013) · GOUT AND NUCLEIC ACID METABOLISM · doi:10.6032/gnam.37.139 · Cited by 539
Terkeltaub, R. A., Furst, D. E., Bennett, K., Kook, K. A., Crockett, R. S., & Davis, M. W. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27327 · Cited by 536
Molecular Mechanism of NLRP3 Inflammasome Activation
Jin, C., & Flavell, R. A. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9440-3 · Cited by 440
Gout and the risk of acute myocardial infarction
Krishnan, E., Baker, J. F., Furst, D. E., & Schumacher, H. R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22014 · Cited by 430
Colchicine Myopathy and Neuropathy
Kuncl, R. W., Duncan, G., Watson, D., Alderson, K., Rogawski, M. A., & Peper, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706183162502 · Cited by 427
Liu‐Bryan, R., Scott, P., Sydlaske, A., Rose, D. M., & Terkeltaub, R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21238 · Cited by 414
Cronstein, B. N., Molad, Y., Reibman, J., Balakhane, E., Levin, R. I., & Weissmann, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118147 · Cited by 388
Mitroulis, I., Kambas, K., Chrysanthopoulou, A., Skendros, P., Apostolidou, E., Kourtzelis, I., Drosos, G. I., Boumpas, D. T., & Ritis, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029318 · Cited by 375
The influence of temperature on the solubility of monosodium urate
Loeb, J. N. (1972) · Arthritis & Rheumatism · doi:10.1002/art.1780150209 · Cited by 337
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.
Borstad, G. C., Bryant, L. R., Abel, M. P., Scroggie, D. A., Harris, M. D., & Alloway, J. A. (2004) · PubMed · Cited by 328
Crucial role of neutrophils in the development of mechanical inflammatory hypernociception
Cunha, T. M., Verri, W. A., Schivo, I. R., Napimoga, M. H., Parada, C. A., Poole, S., Teixeira, M. M., Ferreira, S. H., & Cunha, F. Q. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907654 · Cited by 316
Microtubule motors at the intersection of trafficking and transport
Caviston, J. P., & Holzbaur, E. L. F. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.08.002 · Cited by 303
Mechanisms of inflammation in gout
Busso, N., & So, A. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2952 · Cited by 295
DOES COLCHICINE WORK? THE RESULTS OF THE FIRST CONTROLLED STUDY IN ACUTE GOUT
AHERN, M. J., REID, C., GORDON, T. P., McCREDlE, M., BROOKS, P. M., & JONES, M. (1987) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1987.tb01232.x · Cited by 284
Ng, G., Sharma, K., Ward, S. M., Desrosiers, M. D., Stephens, L. A., Schoel, W. M., Li, T., Lowell, C. A., Ling, C.-C., Amrein, M. W., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.013 · Cited by 276
Melchiorri, C., Meliconi, R., Frizziero, L., Silvestri, T., Pulsatelli, L., Mazzetti, I., Borz�, R. M., Uguccioni, M., & Facchini, A. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2165::aid-art11>3.0.co;2-o · Cited by 253
Martin, W. J., Walton, M., & Harper, J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24185 · Cited by 253
Amaral, F. A., Costa, V. V., Tavares, L. D., Sachs, D., Coelho, F. M., Fagundes, C. T., Soriani, F. M., Silveira, T. N., Cunha, L. D., Zamboni, D. S., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33355 · Cited by 253
EULAR recommendations for calcium pyrophosphate deposition. Part II: Management
Zhang, W., Doherty, M., Pascual, E., Barskova, V, Guerne, P.-A., Jansen, T. L., Leeb, B. F., Perez-Ruiz, F., Pimentao, J., Punzi, L., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139360 · Cited by 252
Di Giovine, F. S., Malawista, S. E., Nuki, G., & Duff, G. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3213 · Cited by 232
Terkeltaub, R. A., Furst, D. E., DiGiacinto, J. L., Kook, K. A., & Davis, M. W. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30389 · Cited by 228
di Giovine, F. S., Malawista, S. E., Thornton, E., & Duff, G. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115142 · Cited by 223
CRITTENDEN, D. B., LEHMANN, R. A., SCHNECK, L., KEENAN, R. T., SHAH, B., GREENBERG, J. D., CRONSTEIN, B. N., SEDLIS, S. P., & PILLINGER, M. H. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111533 · Cited by 222
Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents
Luduena, R. F., & Roach, M. C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90027-j · Cited by 207
Terkeltaub, R., Zachariae, C., Santoro, D., Martin, J., Peveri, P., & Matsushima, K. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340716 · Cited by 202
Nidorf, M., & Thompson, P. L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.10.039 · Cited by 201
Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
Keenan, R. T., O'Brien, W. R., Lee, K. H., Crittenden, D. B., Fisher, M. C., Goldfarb, D. S., Krasnokutsky, S., Oh, C., & Pillinger, M. H. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.09.012 · Cited by 197
Bracey, N. A., Beck, P. L., Muruve, D. A., Hirota, S. A., Guo, J., Jabagi, H., Wright Jr, J. R., MacDonald, J. A., Lees‐Miller, J. P., Roach, D., et al. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.068338 · Cited by 188
Guerne, P., Terkeltaub, R., Zuraw, B., & Lotz, M. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780321114 · Cited by 188
Attur, M., Belitskaya-Lévy, I., Oh, C., Krasnokutsky, S., Greenberg, J., Samuels, J., Smiles, S., Lee, S., Patel, J., Al-Mussawir, H., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30360 · Cited by 187
Yamamoto, M., Yaginuma, K., Tsutsui, H., Sagara, J., Guan, X., Seki, E., Yasuda, K., Yamamoto, M., Akira, S., Nakanishi, K., et al. (2004) · Genes to Cells · doi:10.1111/j.1365-2443.2004.00789.x · Cited by 183
Crystal‐induced neutrophil activation
Popa‐Nita, O., & Naccache, P. H. (2010) · Immunology & Cell Biology · doi:10.1038/icb.2009.98 · Cited by 169
Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages
Landis, R. C., Yagnik, D. R., Florey, O., Philippidis, P., Emons, V., Mason, J. C., & Haskard, D. O. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10614 · Cited by 164
Solubility of uric acid and monosodium urate
Wilcox, W. R., Khalaf, A. A., Weinberger, A., Kippen, I., & Klinenberg, J. R. (1972) · Medical & Biological Engineering & Computing · doi:10.1007/bf02474201 · Cited by 145
TGF-b signaling in cartilage homeostasis and osteoarthritis
Philip, A. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s266 · Cited by 140
Raju, N. C., Yi, Q., Nidorf, M., Fagel, N. D., Hiralal, R., & Eikelboom, J. W. (2011) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-011-0637-y · Cited by 129
Yagnik, D. R., Evans, B., Florey, O., Mason, J. C., Landis, R. C., & Haskard, D. O. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20317 · Cited by 128
Terkeltaub, R. A., Dyer, C. A., Martin, J. G., & Curtiss, L. K. (1991) · Journal of Clinical Investigation · doi:10.1172/jci114971 · Cited by 126
Role of the Sensory Neuron Cytoskeleton in Second Messenger Signaling for Inflammatory Pain
Dina, O. A., McCarter, G. C., de Coupade, C., & Levine, J. D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00473-2 · Cited by 125
Colchicine biotransformation by human liver microsomes
Tateishi, T., Souček, P., Caraco, Y., Guengerich, F. P., & Wood, A. J. J. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00693-4 · Cited by 124
Ding, A. H., Porteu, F., Sánchez, E., & Nathan, C. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.3.715 · Cited by 124
Monosodium Urate Microcrystals Induce Cyclooxygenase-2 in Human Monocytes
Pouliot, M., James, M. J., McColl, S. R., Naccache, P. H., & Cleland, L. G. (1998) · Blood · doi:10.1182/blood.v91.5.1769 · Cited by 122
Bonding the foe – NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals
Schorn, C., Janko, C., Krenn, V., Zhao, Y., Munoz, L. E., Schett, G. A., & i, M. H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00376 · Cited by 117
Ferron, G. M., Rochdi, M., Jusko, W. J., & Scherrmann, J. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04753.x · Cited by 116
Schiltz, C., Lioté, F., Prudhommeaux, F., Meunier, A., Champy, R., Callebert, J., & Bardin, T. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10326 · Cited by 114
Paschke, S., Weidner, A. F., Paust, T., Marti, O., Beil, M., & Ben‐Chetrit, E. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012510 · Cited by 113
Tubulin bound to colchicine forms polymers different from microtubules.
Andreu, J. M., & Timasheff, S. N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6753 · Cited by 111
Chia, E. W., Grainger, R., & Harper, J. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.20 · Cited by 110
Dahan, A., Sabit, H., & Amidon, G. L. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028282 · Cited by 110
Factors affecting urate solubility in vitro.
Kippen, I., Klinenberg, J. R., Weinberger, A., & Wilcox, W. R. (1974) · Annals of the Rheumatic Diseases · doi:10.1136/ard.33.4.313 · Cited by 109
Martin, W. J., Shaw, O. M., Liu, X., Steiger, S., & Harper, J. L. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30249 · Cited by 106
Chen, Y.-H., Hsieh, S., Chen, W., Li, K., Wu, C.-H., Wu, P.-C., Tsai, C., & Yu, C. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.145821 · Cited by 106
Tramontini, N. L., Huber, C. M., Liu‐Bryan, R., Terkeltaub, R. A., & Kilgore, K. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20386 · Cited by 96
Roberge, C., Gaudry, M., de Médicis, R., Lussier, A., Poubelle, P. E., & Naccache, P. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116759 · Cited by 91
Pang, L., Hayes, C., Buac, K., Yoo, D., & Rada, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203215 · Cited by 91
Getting, S. J., Flower, R. J., Parente, L., de Médicis, R., Lussier, A., Woliztky, B. A., Martins, M. A., & Perretti, M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37005-3 · Cited by 90
Terkeltaub, R. A., Curtiss, L. K., Tenner, A. J., & Ginsberg, M. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111380 · Cited by 89
Factors affecting the solubility of calcium pyrophosphate dihydrate crystals.
Bennett, R. M., Lehr, J. R., & McCarty, D. J. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108239 · Cited by 87
Akahoshi, T., Namai, R., Murakami, Y., Watanabe, M., Matsui, T., Nishimura, A., Kitasato, H., Kameya, T., & Kondo, H. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10709 · Cited by 83
Kuijpers, T. W., Raleigh, M., Kavanagh, T. J., Janssen, H., Calafat, J., Roos, D., & Harlan, J. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5060 · Cited by 81
Mast cells are potent regulators of endothelial cell adhesion molecule ICAM‐1 and VCAM‐1 expression
Meng, H., Tonnesen, M. G., Marchese, M. J., Clark, R. A. F., Bahou, W. F., & Gruber, B. L. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650106 · Cited by 81
Lioté, F., Prudhommeaux, F., Schiltz, C., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390718 · Cited by 80
Scanu, A., Oliviero, F., Ramonda, R., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200711 · Cited by 80
Microtubule-mediated NF-κB activation in the TNF-α signaling pathway
Jackman, R. W., Rhoads, M. G., Cornwell, E. W., & Kandarian, S. C. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.08.020 · Cited by 79
Madrigal‐Matute, J., Martínez-Pinna, R., Ramos‐Mozo, P., Blanco‐Colio, L. M., Moreno, J. A., Tarín, C., Burillo, E., Fernandez‐Garcia, C. E., Egido, J., Meilhac, O., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-04-0248 · Cited by 79
Acute Myopathy in a Patient with Concomitant Use of Pravastatin and Colchicine
Alaylı, G., Cengiz, K., Cantürk, F., Durmuş, D., Akyol, Y., & Menekse, E. B. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e593 · Cited by 79
2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia
Hamburger, M. I., Baraf, H. S. B., Adamson, T. C., Basile, J., Bass, L., Cole, B., Doghramji, P. P., Guadagnoli, G. A., Hamburger, F., Harford, R., et al. (2011) · The Physician and Sportsmedicine · doi:10.3810/psm.2011.11.1946 · Cited by 76
A Role of IgM Antibodies in Monosodium Urate Crystal Formation and Associated Adjuvanticity
Kanevets, U., Sharma, K., Dresser, K., & Shi, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803777 · Cited by 74
Justiniano, M. E., Dold, S., & Espinoza, L. R. (2007) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318156d977 · Cited by 71
Giclas, P. C., Ginsberg, M. H., & Cooper, N. R. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109360 · Cited by 69
Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout
Dalbeth, N., & Merriman, T. R. (2008) · Rheumatology · doi:10.1093/rheumatology/ken460 · Cited by 67
Self-citationStudies of urate crystallisation in relation to gout.
Fiddis, R. W., Vlachos, N., & Calvert, P. (1983) · Annals of the Rheumatic Diseases · doi:10.1136/ard.42.suppl_1.12 · Cited by 64
Iwata, H., Nishio, S., Yokoyama, M., et al. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)39003-1 · Cited by 54
Cunha, T. M., Talbot, J., Pinto, L. G., Vieira, S. M., de Souza, G. R., Guerrero, A. T., Sônego, F., Verri, W. A., Jr., Zamboni, D. S., Ferreira, S. H., et al. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-63 · Cited by 54
Oka, T., Hori, M., & Ozaki, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4584 · Cited by 52
Russell, I. J., Mansen, C., Kolb, L. M., et al. (1982) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(82)90235-5 · Cited by 51
Perl‐Treves, D., Addadi, L., & Thomas, J. M. (1988) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1988.0069 · Cited by 50
Steiger, S., & Harper, J. L. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37822 · Cited by 46
Possible colchicine rhabdomyolysis in a fluvastatin-treated patient
Atasoyu, E. M., Evrenkaya, T. R., & Solmazgül, E. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e653 · Cited by 45
The effect of colchicine on pyrin and pyrin interacting proteins
Taşkıran, E. Z., Çetinkaya, A., Balcı‐Peynircioğlu, B., Akkaya‐Ulum, Y. Z., & Yılmaz, E. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24231 · Cited by 44
Aran, S., Malekzadeh, S., & Seifirad, S. (2011) · PubMed · Cited by 44
Microcrystals as DAMPs and their role in joint inflammation
Busso, N., & So, A. (2012) · Rheumatology · doi:10.1093/rheumatology/ker524 · Cited by 43
Hearn, P. R., & Russell, R. G. G. (1980) · Annals of the Rheumatic Diseases · doi:10.1136/ard.39.3.222 · Cited by 42
Activation of the alternative pathway of complement by monosodium urate crystals
Fields, T. R., Abramson, S. B., Weissmann, G., et al. (1983) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(83)90143-5 · Cited by 40
Şahin, M., Uğuz, A. C., Demirkan, H., & Nazıroğlu, M. (2011) · The Journal of Membrane Biology · doi:10.1007/s00232-011-9342-1 · Cited by 27
Lim, S., Bae, E., Kim, H.-S., Kim, T.-A., Byun, K., Kim, B.-C., Hong, S., Im, J. P., Yun, C., Lee, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032705 · Cited by 23
Schuligoi, R. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005251 · Cited by 21
Ning, L., Wang, X., Fan, X., Ding, X., Wang, Y., Zhang, Y., Wang, J., & Yue, S. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000261 · Cited by 17
Modulation of TGF-β signaling by proinflammatory cytokines in articular chondrocytes
Roman‐Blas, J. A., Stokes, D. G., & Jiménez, S. A. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.04.011 · Cited by 1
Cited by
Colchicine in Patients with Chronic Coronary Disease
Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., The, S. H. K., Xu, X.-F., Ireland, M. A., Lenderink, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021372 · Cited by 2,299
Gout: An old disease in new perspective – A review
Ragab, G., Elshahaly, M., & Bardin, T. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.04.008 · Cited by 599
Najmi, A., Javed, S. A., Al Bratty, M., & Alhazmi, H. A. (2022) · Molecules · doi:10.3390/molecules27020349 · Cited by 596
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
Bardin, T., & Richette, P. (2017) · BMC Medicine · doi:10.1186/s12916-017-0890-9 · Cited by 385
Physiology of Hyperuricemia and Urate-Lowering Treatments
Benn, C. L., Dua, P., Gurrell, R., Loudon, P., Pike, A., Storer, R. I., & Vangjeli, C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00160 · Cited by 319
Metadata
- Authors
- Dalbeth, N., Lauterio, T. J., & Wolfe, H. R.
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 36
- Issue
- 10
- Pages
- 1465-1479
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2172081252
- Cited by
- 416
- References
- 111
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.